Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Short-term Investments (2023 - 2026)

BioAge Labs' Short-term Investments history spans 2 years, with the latest figure at $92.2 million for Q4 2025.

  • On a quarterly basis, Short-term Investments changed N/A to $92.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $92.2 million, a N/A change, with the full-year FY2025 number at $92.2 million, changed N/A from a year prior.
  • Short-term Investments hit $92.2 million in Q4 2025 for BioAge Labs, up from $70.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for BIOA hit a ceiling of $92.2 million in Q4 2025 and a floor of $3.3 million in Q4 2023.